2013      2012     2011     2010     2009     2008     2007     2006     2005     2004     2003     journal covers          PubMed Search  

1. Casadevall, A. 2003. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun 71:4225-8.

2. Casadevall, A., and L. A. Pirofski. 2003. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 1:17-24.

3. Casadevall, A., and L. A. Pirofski. 2003. "Anti-virulence" genes--further muddling the lexicon? Response from Arturo Casadevall and Liise-anne Pirofski. Trends Microbiol 11:413-4.

4. Casadevall, A., and L. A. Pirofski. 2003. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol 24:474-8.

5. Casadevall, A., and L. A. Pirofski. 2003. Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. J Exp Med 197:1401-4.

6. Casadevall, A., and L. A. Pirofski. 2003. Microbial virulence results from the interaction between host and microorganism. Trends Microbiol 11:157-8; author reply 158-9.

7. Casadevall, A., J. N. Steenbergen, and J. D. Nosanchuk. 2003. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm. Curr Opin Microbiol 6:332-7.

8. Cox, G. M., T. S. Harrison, H. C. McDade, C. P. Taborda, G. Heinrich, A. Casadevall, and J. R. Perfect. 2003. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infect Immun 71:173-80.

9. Dadachova, E., A. Nakouzi, R. A. Bryan, and A. Casadevall. 2003. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A 100:10942-7.

10. Datta, K., N. Jain, S. Sethi, A. Rattan, A. Casadevall, and U. Banerjee. 2003. Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care. J Antimicrob Chemother 52:683-6.

11. He, W., A. Casadevall, S. C. Lee, and D. L. Goldman. 2003. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infect Immun 71:930-6.

12. Mednick, A. J., M. Feldmesser, J. Rivera, and A. Casadevall. 2003. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol 33:1744-53.

13. Monari, C., C. Retini, A. Casadevall, D. Netski, F. Bistoni, T. R. Kozel, and A. Vecchiarelli. 2003. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Eur J Immunol 33:1041-51.

14. Morris-Jones, R., S. Youngchim, B. L. Gomez, P. Aisen, R. J. Hay, J. D. Nosanchuk, A. Casadevall, and A. J. Hamilton. 2003. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect Immun 71:4026-33.

15. Nakouzi, A., and A. Casadevall. 2003. The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan. Mol Immunol 40:351-61.

16. Navoa, J. A., S. Laal, L. A. Pirofski, G. R. McLean, Z. Dai, J. B. Robbins, R. Schneerson, A. Casadevall, and A. Glatman-Freedman. 2003. Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clin Diagn Lab Immunol 10:88-94.

17. Nosanchuk, J. D., and A. Casadevall. 2003. Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa. Microbiology 149:1945-51.

18. Nosanchuk, J. D., and A. Casadevall. 2003. The contribution of melanin to microbial pathogenesis. Cell Microbiol 5:203-23.

19. Nosanchuk, J. D., A. Mednick, L. Shi, and A. Casadevall. 2003. Experimental murine cryptococcal infection results in contamination of bedding with Cryptococcus neoformans. Contemp Top Lab Anim Sci 42:9-12.

20. Nosanchuk, J. D., J. N. Steenbergen, L. Shi, G. S. Deepe, Jr., and A. Casadevall. 2003. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest 112:1164-75.

21. Pietrella, D., B. Fries, P. Lupo, F. Bistoni, A. Casadevall, and A. Vecchiarelli. 2003. Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Cell Microbiol 5:513-22.

22. Steenbergen, J. N., and A. Casadevall. 2003. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 5:667-75.

23. Steenbergen, J. N., J. D. Nosanchuk, S. D. Malliaris, and A. Casadevall. 2003. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect Immun 71:4862-72.

24. Sweeney, D. A., M. T. Caserta, D. N. Korones, A. Casadevall, and D. L. Goldman. 2003. A ten-year-old boy with a pulmonary nodule secondary to Cryptococcus neoformans: case report and review of the literature. Pediatr Infect Dis J 22:1089-93.

25. Taborda, C. P., J. Rivera, O. Zaragoza, and A. Casadevall. 2003. More is not necessarily better: prozone-like effects in passive immunization with IgG. J Immunol 170:3621-30.

26. Tian, S., J. Garcia-Rivera, B. Yan, A. Casadevall, and R. E. Stark. 2003. Unlocking the molecular structure of fungal melanin using 13C biosynthetic labeling and solid-state NMR. Biochemistry 42:8105-9.

27. Vecchiarelli, A., D. Pietrella, P. Lupo, F. Bistoni, D. C. McFadden, and A. Casadevall. 2003. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. J Leukoc Biol 74:370-8.

28. Wang, F., A. Nakouzi, R. H. Angeletti, and A. Casadevall. 2003. Site-specific characterization of the N-linked oligosaccharides of a murine immunoglobulin M by high-performance liquid chromatography/electrospray mass spectrometry. Anal Biochem 314:266-80.

29. Zaragoza, O., B. C. Fries, and A. Casadevall. 2003. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun 71:6155-64.

30. Zaragoza, O., C. P. Taborda, and A. Casadevall. 2003. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol 33:1957-67.